Doshi Medicare Private Limited — Rituximab Exporter Profile

Doshi Medicare Private Limited exports Rituximab to 6 countries. The largest destination is SAUDI ARABIA accounting for 81.3% of Doshi Medicare Private Limited's Rituximab shipments, followed by TANZANIA (7.8%) and SOMALIA (4.3%). These destinations reflect Doshi Medicare Private Limited's established distribution network and regulatory approvals in key markets.

Doshi Medicare Private Limited supplies Rituximab to 2 buyers globally. The largest buyer is TO THE ORDER OF (ETHIOPIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

Doshi Medicare Private Limited exports 11 distinct Rituximab formulations including tablets, capsules, syrups, and combination drugs. The top formulation is MEDICINES FOR CONSUMPTION AND THE DESCRIPTION OF THE PRODUCT with 3 shipments worth $29.2K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

Doshi Medicare Private Limited ranks #14 among 164 Indian Rituximab exporters. Average shipment value of $4.0K compared to the market average of $57.4K. The closest competitors by value are SANSKRUTI PHARMA and HEET HEALTHCARE PRIVATE LIMITED.